Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Operating Expenses | 22,481 | 6,592 | 7,947 | 3,284 | 26 |
| Operating Income | -22,481 | -6,592 | -7,947 | -3,284 | -26 |
| Interest Expense | 1 | 3 | 1,099 | 175 | 6 |
| Other Income | -2,206 | -4,179 | 685 | 14 | 34 |
| Pre-tax Income | -24,688 | -10,774 | -8,361 | -3,445 | 2 |
| Net Income Continuous | -24,688 | -10,774 | -8,361 | -3,445 | 2 |
| Net Income | $-24,688 | $-10,774 | $-8,361 | $-3,445 | $2 |
| EPS Basic Total Ops | -27.03 | -14.11 | -227.63 | -129.13 | 0.30 |
| EPS Basic Continuous Ops | -27.09 | -14.22 | -227.43 | -128.99 | 0.00 |
| EPS Diluted Total Ops | -27.03 | -14.11 | -227.63 | -129.13 | 0.30 |
| EPS Diluted Continuous Ops | -27.09 | -14.22 | -227.43 | -128.99 | 0.00 |
| EBITDA(a) | $-22,443 | $-6,590 | $-6,919 | $-3,118 | $-26 |